Michael Kreines
Gastroenterology · Cincinnati, OHNPI 1194714907
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 27.4% of the total. Reporting peaked in 2019 at $648 and has fallen 78.4% since, to $140 in 2022. That places this record below the midpoint for gastroenterology clinicians in OH, where the typical reported total is $2,203.
Across 92 payments — averaging $13.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$341
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$177
- Pfizer$152
- Takeda Pharmaceuticals U.S.A., Inc.$136
- Nestle Healthcare Nutrition Inc.$68
- Gilead$60
- plus $310 from 11 others
Across 86 payments — averaging $2811.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$156K
- Braintree Laboratories, Inc.$39K
- Janssen Research & Development, LLC$23K
- E.r. Squibb & Sons, L.L.C.$10K
- UCB Biosciences Inc.$7K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$7K
What the payments were for
- Food & beverage$1,244100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $341 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $177 |
| Pfizer | 11 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $136 |
| Nestle Healthcare Nutrition Inc. | 4 | $68 |
| Gilead | 5 | $60 |
| Bristol Myers Squibb | 4 | $55 |
| Amgen | 3 | $53 |
| QOL Medical, LLC | 4 | $50 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Merck | 2 | $28 |
| UCB, Inc. | 2 | $27 |
| Shire North American Group Inc | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
| Boston Scientific | 1 | $11 |
How this compares
$1,244 in reported general payments places this provider in the 35th percentile of 657 gastroenterology providers in Ohio.
Other gastroenterology in Cincinnati
- Anita AfzaliCincinnati$798K
- Kara de FeliceCincinnati$427K
- Allan PeckCincinnati$391K
- Ravi RavinuthalaCincinnati$302K
- Robert IsfortCincinnati$162K
- Luis LaraCincinnati$146K
- Vidhya KunnathurCincinnati$96K
- Moamen GabrCincinnati$70K
- Lisa LestinaCincinnati$59K
- Naim AlkhouriWestlake$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.